出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年5月
Medical Polymer Market – Global Forecast To 2029
医療用ポリマー市場 : タイプ（医療用プラスチック、医療用エラストマー）、用途（医療用使い捨て製品、医療機器＆装置、補綴物、診断用器具＆ツール）、製造技術、地域別 – 2029年までの世界予測
Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments And Devices, Prosthetics, Diagnostics Instruments And Tools), Manufacturing Technology, and Region – Global Forecast to 2029
| ページ数 | 427 |
| 図表数 | 397 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
[myphp file=”contact”] 出版社・価格・納期について
Report Overview
The global medical polymer market is expected to grow at a CAGR of 8.0% during the forecast period, from an estimated USD 41.1 million in 2024 to USD 60.5 million by 2029.
世界の医療用ポリマー市場は、予測期間中に8.0%のCAGRで成長し、2024年の推定4,110万米ドルから2029年までに6,050万米ドルに達すると予想されています。
The demand for medical polymers is increasing due to the growing emphasis on healthcare quality and safety, leading to the development of innovative medical devices and equipment. Additionally, advancements in polymer technology have expanded the capabilities and applications of medical polymers, driving their adoption across various medical fields. This rising demand is also fueled by the need for materials that offer biocompatibility, durability, and ease of sterilization in medical settings.
“Medical elastomers accounted for the second largest share in type segment of medical polymer market in terms of value.”
Medical elastomers hold the second-largest market share in the medical polymer segment due to their unique properties and versatility in medical applications. These elastomers offer characteristics such as flexibility, resilience, and biocompatibility, making them ideal for use in medical devices and components that require elasticity and durability, such as catheters, seals, and surgical gloves. The demand for medical elastomers is also driven by their ability to withstand sterilization processes and harsh chemical environments commonly found in healthcare settings. Furthermore, ongoing developments in elastomer formulations and processing techniques continue to enhance their performance and expand their applications, contributing to their significant market presence in the medical polymer industry.
“Medical disposables accounted for the second largest share in application segment of medical polymer market in terms of value.”
Medical disposables hold the second-largest market share in the application segment of the medical polymer market due to several key factors. Firstly, the increasing focus on infection control and patient safety has driven the demand for single-use medical products, such as syringes, gloves, and surgical drapes, made from medical polymers. These disposables offer convenience, sterility, and reduced risk of cross-contamination, making them essential in healthcare settings. Additionally, the rise in outpatient and home-based care has led to higher consumption of disposable medical supplies. Moreover, advancements in polymer technology have enabled the development of cost-effective and environmentally friendly disposable medical products, further fueling their adoption and contributing to their significant market share.
“Injection molding accounted for the second largest share in the manufacturing technology segment of medical polymer market in terms of value.”
Injection molding holds the second-largest market share in the manufacturing technology segment of the medical polymer market due to its efficiency, precision, and versatility. This technology allows for the mass production of intricate and customized medical components with consistent quality and dimensional accuracy. Medical devices and products manufactured through injection molding, such as syringes, IV catheters, and implantable devices, benefit from properties like biocompatibility, sterilizability, and durability. Additionally, injection molding offers cost-effective production, shorter lead times, and reduced material wastage, making it highly favored by medical device manufacturers. Moreover, ongoing advancements in injection molding technology, including automation and digitalization, further enhance its capabilities and market competitiveness in the medical polymer industry.
“Europe is the second-largest market for medical polymer.”
Europe holds the second-largest market share globally in the medical polymer market due to several key factors. Firstly, the region benefits from a well-established healthcare infrastructure, advanced research and development capabilities, and stringent regulatory standards, fostering innovation and quality in medical polymer products. Additionally, the increasing aging population and prevalence of chronic diseases drive the demand for advanced medical devices and equipment, which rely heavily on medical polymers. Moreover, Europe’s strong emphasis on healthcare modernization, sustainability, and patient safety further propels the adoption of medical polymers. Furthermore, strategic collaborations between industry players, research institutions, and healthcare providers contribute to the region’s leadership in the global medical polymer market.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the medical polymer market, and information was gathered from secondary research to determine and verify the market size of several segments.
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C Level Executives– 20%, Directors – 10%, and Others – 70%
- By Region: North America – 20%, Europe – 20%, APAC – 40%, South America- 10% , and Middle East & Africa –10%
The medical polymer market comprises major players such as BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), DuPont (US), and others. The study includes in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This report segments the market for medical polymer market on the basis of type, application, manufacturing technology, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, new product launches, expansions, and mergers & acquisition associated with the market for medical polymer market.
Key benefits of buying this report
This research report is focused on various levels of analysis — industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view on the competitive landscape; emerging and high-growth segments of the medical polymer market; high-growth regions; and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the medical polymer market offered by top players in the global medical polymer market.
• Analysis of drivers: (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), and challenges (Cost constraints for novel materials, Long term durability and degradation control) influencing the growth of medical polymer market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical polymer market.
• Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical polymer market across regions.
• Market Capacity: Production capacities of companies producing medical polymer are provided wherever available with upcoming capacities for the medical polymer market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical polymer market.
Table of Contents
1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.3 INCLUSIONS AND EXCLUSIONS 40
TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS 40
1.4 STUDY SCOPE 41
FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION 41
1.4.1 YEARS CONSIDERED 42
1.5 CURRENCY CONSIDERED 42
1.6 UNITS CONSIDERED 42
1.7 STAKEHOLDERS 42
1.8 IMPACT OF RECESSION 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 List of major secondary sources 45
2.1.1.2 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
2.1.2.1 Primary data sources: demand and supply sides 46
2.1.2.2 Key data from primary sources 46
2.1.2.3 Key industry insights 47
2.1.2.4 Breakdown of primary interviews 47
2.2 MARKET SIZE ESTIMATION 48
FIGURE 3 MARKET SIZE ESTIMATION APPROACH: DEMAND SIDE 48
2.2.1 BOTTOM-UP APPROACH 49
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 49
2.2.2 TOP-DOWN APPROACH 49
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 49
2.3 DATA TRIANGULATION 50
FIGURE 6 MEDICAL POLYMER MARKET: DATA TRIANGULATION 50
2.4 RESEARCH ASSUMPTIONS 51
2.5 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 51
2.5.1 SUPPLY SIDE 51
2.5.2 DEMAND SIDE 51
2.6 RESEARCH LIMITATION 52
2.7 RISK ASSESSMENT 52
3 EXECUTIVE SUMMARY 53
FIGURE 7 MEDICAL PLASTICS SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD 54
FIGURE 8 MEDICAL INSTRUMENTS & DEVICES TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD 54
FIGURE 9 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 55
4 PREMIUM INSIGHTS 56
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET 56
FIGURE 10 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD 56
4.2 MEDICAL POLYMER MARKET, BY TYPE 56
FIGURE 11 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD 56
4.3 MEDICAL POLYMER MARKET, BY APPLICATION 57
FIGURE 12 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 57
4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 57
FIGURE 13 EXTRUSION TUBING SEGMENT TO ACCOUNT FOR LARGEST SHARE OF MEDICAL POLYMER MARKET 57
4.5 MEDICAL POLYMER MARKET, BY COUNTRY 58
FIGURE 14 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 15 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Increasing demand for biocompatible materials 60
5.2.1.2 Growing aging population globally 60
5.2.1.3 Advancements in medical technology 61
5.2.1.4 Regulatory support for medical-grade materials 61
5.2.2 RESTRAINTS 62
5.2.2.1 Regulatory complexities and approvals 62
5.2.2.2 High competition from alternative materials 62
5.2.2.3 Environmental sustainability concerns 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Growth in regenerative medicine 63
5.2.3.2 Demand for minimally invasive devices 64
5.2.3.3 Advancements in biodegradable polymers 64
5.2.4 CHALLENGES 65
5.2.4.1 Cost constraints for novel materials 65
5.2.4.2 Long-term durability and degradation control 65
5.3 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 2 MEDICAL POLYMER MARKET: PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 16 PORTER’S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET 66
5.3.1 THREAT FROM NEW ENTRANTS 67
5.3.2 THREAT OF SUBSTITUTES 67
5.3.3 BARGAINING POWER OF BUYERS 67
5.3.4 BARGAINING POWER OF SUPPLIERS 68
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.4 MACROECONOMIC INDICATORS 68
5.4.1 GLOBAL GDP TRENDS 69
TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018–2025 69
6 INDUSTRY TRENDS 70
6.1 INTRODUCTION 70
6.2 KEY STAKEHOLDERS & BUYING CRITERIA 70
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 70
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 71
6.2.2 BUYING CRITERIA 71
FIGURE 18 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 71
TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 72
6.3 VALUE CHAIN ANALYSIS 72
FIGURE 19 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS 72
6.3.1 RAW MATERIAL 73
6.3.2 MANUFACTURER 73
6.3.3 DISTRIBUTION 73
6.3.4 END USER 73
6.4 ECOSYSTEM ANALYSIS 74
FIGURE 20 MEDICAL POLYMER MARKET: ECOSYSTEM MAPPING 74
TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM 74
6.5 CASE STUDY ANALYSIS 75
6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS 75
6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY 75
6.6 REGULATORY LANDSCAPE 76
TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
6.7 TECHNOLOGY ANALYSIS 78
6.7.1 KEY TECHNOLOGY 78
6.7.2 COMPLEMENTARY TECHNOLOGY 79
6.7.3 ADJACENT TECHNOLOGY 79
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 79
6.8.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MEDICAL POLYMER MANUFACTURERS 79
FIGURE 21 REVENUE SHIFT IN MEDICAL POLYMER MARKET 80
6.9 TRADE ANALYSIS 80
6.9.1 IMPORT SCENARIO 80
FIGURE 22 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019–2022 (USD THOUSAND) 80
6.9.2 EXPORT SCENARIO 81
FIGURE 23 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2019–2022 (USD THOUSAND) 81
6.10 KEY CONFERENCES & EVENTS 82
TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2024−2025 82
6.11 PRICING ANALYSIS 83
6.11.1 AVERAGE SELLING PRICE TREND, BY REGION 83
FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION (USD/KILOTON) 83
6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION 84
FIGURE 25 AVERAGE SELLING PRICE TREND, BY APPLICATION (USD/KILOTON) 84
6.11.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION 84
FIGURE 26 AVERAGE SELLING PRICE, BY KEY MARKET PLAYERS (USD/ KILOTON) 84
6.12 INVESTMENT AND FUNDING SCENARIO 85
FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION) 85
6.13 PATENT ANALYSIS 85
6.13.1 METHODOLOGY 85
6.13.2 PATENTS GRANTED WORLDWIDE, 2013–2023 86
TABLE 12 TOTAL NUMBER OF PATENTS 86
6.13.3 PATENT PUBLICATION TRENDS 86
FIGURE 28 TOTAL NUMBER OF PATENTS PUBLISHED FROM 2013 TO 2023 86
6.13.4 INSIGHTS 87
6.13.5 LEGAL STATUS OF PATENTS 87
FIGURE 29 PATENT ANALYSIS, BY LEGAL STATUS 87
6.13.6 JURISDICTION-WISE PATENT ANALYSIS 87
FIGURE 30 TOP JURISDICTIONS FOR MEDICAL POLYMER PATENTS 87
6.13.7 TOP COMPANIES/APPLICANTS 88
FIGURE 31 TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENTS 88
6.13.8 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 89
TABLE 13 TOP TEN PATENT OWNERS 89
7 MEDICAL POLYMER MARKET, BY TYPE 90
7.1 INTRODUCTION 91
FIGURE 32 MEDICAL PLASTICS TO LEAD OVERALL MARKET DURING FORECAST PERIOD 91
TABLE 14 MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 92
TABLE 15 MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 93
TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 94
TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 95
7.2 MEDICAL PLASTICS 96
7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET 96
7.2.2 POLYPROPYLENE (PP) 96
7.2.3 POLYVINYL CHLORIDE (PVC) 96
7.2.4 POLYETHYLENE (PE) 96
7.2.5 POLYSTYRENE (PS) 96
7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS 97
7.2.6.1 Polyether ether ketone (PEEK) 97
7.2.6.2 Nylon/polyamide (PA) 97
7.2.6.3 Polyphenulsulfone (PPSU) 97
7.2.6.4 Polysulfones (PSU) 97
7.2.6.5 Polymethyl methacrylate (PMMA) 97
7.2.6.6 Polycarbonate (PC) 97
7.2.6.7 Acrylonitrile butadiene styrene (ABS) 97
7.2.6.8 Other engineering & high-performance plastics 98
7.2.7 OTHER MEDICAL PLASTICS 98
7.3 MEDICAL ELASTOMERS 98
7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET 98
7.3.2 SILICONE 98
7.3.3 THERMOPLASTIC ELASTOMERS 98
7.3.3.1 Thermoplastic polyurethane (TPU) 98
7.3.3.2 Thermoplastic vulcanizates (TPV) 99
7.3.3.3 Thermoplastic styrenic elastomers (TPS) 99
7.3.3.3.1 Poly(styrene-butadiene-styrene) (SBS) 99
7.3.3.3.2 Styrene-ethylene-butylene-styrene (SEBS) 99
7.3.3.4 Thermoplastic copolyester elastomers (TPC-ET) 99
7.4 OTHER MEDICAL ELASTOMERS 99
8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 100
8.1 INTRODUCTION 101
FIGURE 33 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 101
TABLE 18 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 101
TABLE 19 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 102
TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 102
TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 102
8.2 EXTRUSION TUBING 103
8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET 103
8.3 COMPRESSION MOLDING 103
8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET 103
8.4 INJECTION MOLDING 103
8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET 103
8.5 OTHER MANUFACTURING TECHNOLOGIES 104
9 MEDICAL POLYMER MARKET, BY APPLICATION 105
9.1 INTRODUCTION 106
FIGURE 34 MEDICAL INSTRUMENTS & DEVICES TO BE LARGEST APPLICATION OF MEDICAL POLYMER 106
TABLE 22 MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 107
TABLE 23 MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 108
TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 109
TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 110
9.2 MEDICAL DISPOSABLES 111
9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET 111
9.2.2 GLOVES 111
9.2.3 SYRINGES 111
9.2.4 MEDICAL BAGS 112
9.2.5 OTHER MEDICAL DISPOSABLES 112
9.3 MEDICAL INSTRUMENTS & DEVICES 113
9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 113
9.3.2 MEDICAL TUBES 113
9.3.3 CATHETERS 113
9.3.4 DRUG DELIVERY 114
9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES 114
9.4 PROSTHETICS 115
9.4.1 TECHNOLOGICAL DEVELOPMENTS TO DRIVE DEMAND 115
9.4.2 IMPLANTS 115
9.4.3 LIMB PROSTHESIS 115
9.4.4 OTHER PROSTHETICS APPLICATIONS 116
9.5 DIAGNOSTIC INSTRUMENTS & TOOLS 116
9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 116
9.5.2 DENTAL TOOLS 116
9.5.3 SURGICAL INSTRUMENTS 116
9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS 117
9.6 OTHER APPLICATIONS 117
10 MEDICAL POLYMER MARKET, BY REGION 118
10.1 INTRODUCTION 119
FIGURE 35 MEDICAL POLYMER MARKET SNAPSHOT 119
TABLE 26 MEDICAL POLYMER MARKET, BY REGION, 2020–2023 (USD MILLION) 119
TABLE 27 MEDICAL POLYMER MARKET, BY REGION, 2024–2029 (USD MILLION) 120
TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2020–2023 (KILOTON) 120
TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2024–2029 (KILOTON) 120
10.2 NORTH AMERICA 121
10.2.1 IMPACT OF RECESSION ON NORTH AMERICA 121
FIGURE 36 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT 122
TABLE 30 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 122
TABLE 31 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 123
TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON) 123
TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON) 123
TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 124
TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 125
TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 126
TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 127
TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 128
TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 129
TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 130
TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 131
TABLE 42 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 131
TABLE 43 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 132
TABLE 44 NORTH AMERICA, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 132
TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 132
10.2.2 US 133
10.2.2.1 High R&D investments in medical sector to drive market growth 133
TABLE 46 US: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 133
TABLE 47 US: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 134
TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 135
TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 136
TABLE 50 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 137
TABLE 51 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 138
TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 139
TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 140
10.2.3 CANADA 140
10.2.3.1 Emerging demand for dental implants to drive market 140
TABLE 54 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 141
TABLE 55 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 142
TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 143
TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 144
TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 145
TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 146
TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 147
TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 148
10.2.4 MEXICO 148
10.2.4.1 Rising focus of manufacturers to expand manufacturing facilities to drive market growth 148
TABLE 62 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 149
TABLE 63 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 150
TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 151
TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 152
TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 153
TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 154
TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 155
TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 156
10.3 ASIA PACIFIC 157
10.3.1 RECESSION IMPACT 157
FIGURE 37 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT 158
TABLE 70 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 159
TABLE 71 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 159
TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON) 159
TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON) 160
TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 160
TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 161
TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 162
TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 163
TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 164
TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 165
TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 166
TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 167
TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 167
TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 168
TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 168
TABLE 85 ASIA PACIFIC, MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 168
10.3.2 CHINA 169
10.3.2.1 Largest market for medical polymers in Asia Pacific 169
TABLE 86 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 169
TABLE 87 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 170
TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 171
TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 172
TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 173
TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 173
TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 174
TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 175
10.3.3 INDIA 175
10.3.3.1 Rapid economic growth and growing population to drive market growth 175
TABLE 94 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 176
TABLE 95 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 177
TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 178
TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 179
TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 180
TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 181
TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 182
TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 183
10.3.4 SOUTH KOREA 183
10.3.4.1 Advanced healthcare and medical technologies to propel market growth 183
TABLE 102 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 184
TABLE 103 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 185
TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 186
TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 187
TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 188
TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 189
TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 190
TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 191
10.3.5 JAPAN 191
10.3.5.1 Developments in minimally invasive treatment and robotic surgery to support market growth 191
TABLE 110 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 192
TABLE 111 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 193
TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 194
TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 195
TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 196
TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 197
TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 198
TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 199
10.3.6 AUSTRALIA 199
10.3.6.1 Regulatory compliance and strategic collaborations to support market growth 199
TABLE 118 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 200
TABLE 119 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 201
TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 202
TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 203
TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 204
TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 205
TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 206
TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 207
10.3.7 REST OF ASIA PACIFIC 207
TABLE 126 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 208
TABLE 127 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 209
TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 210
TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 211
TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 212
TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 213
TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 214
TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 215
10.4 EUROPE 215
10.4.1 RECESSION IMPACT 216
FIGURE 38 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT 217
TABLE 134 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 218
TABLE 135 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 218
TABLE 136 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON) 218
TABLE 137 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON) 219
TABLE 138 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 219
TABLE 139 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 220
TABLE 140 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 221
TABLE 141 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 222
TABLE 142 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 223
TABLE 143 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 224
TABLE 144 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 225
TABLE 145 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 226
TABLE 146 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 226
TABLE 147 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 227
TABLE 148 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 227
TABLE 149 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 227
10.4.2 GERMANY 228
10.4.2.1 Rising demand in dental implant application to drive market 228
TABLE 150 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 229
TABLE 151 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 230
TABLE 152 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 231
TABLE 153 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 232
TABLE 154 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 233
TABLE 155 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 234
TABLE 156 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 235
TABLE 157 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 236
10.4.3 FRANCE 236
10.4.3.1 Aging population and sedentary lifestyle to drive demand 236
TABLE 158 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 237
TABLE 159 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 238
TABLE 160 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 239
TABLE 161 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 240
TABLE 162 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 241
TABLE 163 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 242
TABLE 164 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 243
TABLE 165 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 244
10.4.4 UK 244
10.4.4.1 Growing incidences of chronic diseases and government support for innovation to drive market 244
TABLE 166 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 245
TABLE 167 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 246
TABLE 168 UK: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 247
TABLE 169 UK: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 248
TABLE 170 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 249
TABLE 171 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 250
TABLE 172 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 251
TABLE 173 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 252
10.4.5 ITALY 252
10.4.5.1 Strong production facilities with presence of global players to propel market growth 252
TABLE 174 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 253
TABLE 175 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 254
TABLE 176 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 255
TABLE 177 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 256
TABLE 178 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 257
TABLE 179 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 258
TABLE 180 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 259
TABLE 181 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 260
10.4.6 SPAIN 260
10.4.6.1 Increase in government funding for healthcare sector to support market 260
TABLE 182 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 261
TABLE 183 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 262
TABLE 184 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 263
TABLE 185 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 264
TABLE 186 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 265
TABLE 187 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 266
TABLE 188 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 267
TABLE 189 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 268
10.4.7 REST OF EUROPE 268
TABLE 190 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 269
TABLE 191 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 270
TABLE 192 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 271
TABLE 193 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 272
TABLE 194 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 273
TABLE 195 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 274
TABLE 196 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 275
TABLE 197 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 276
10.5 MIDDLE EAST & AFRICA 276
10.5.1 RECESSION IMPACT 277
TABLE 198 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 277
TABLE 199 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 277
TABLE 200 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON) 278
TABLE 201 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON) 278
TABLE 202 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 279
TABLE 203 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 280
TABLE 204 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 281
TABLE 205 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 282
TABLE 206 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 283
TABLE 207 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 284
TABLE 208 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 285
TABLE 209 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 286
TABLE 210 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 286
TABLE 211 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 287
TABLE 212 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 287
TABLE 213 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 287
10.5.2 SAUDI ARABIA 288
10.5.2.1 Growing population and rise in aging population to drive market 288
TABLE 214 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 289
TABLE 215 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 290
TABLE 216 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 291
TABLE 217 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 292
TABLE 218 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 293
TABLE 219 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 294
TABLE 220 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 295
TABLE 221 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 296
10.5.3 UAE 296
10.5.3.1 Population growth and changing epidemiology expected to drive market growth 296
TABLE 222 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 297
TABLE 223 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 298
TABLE 224 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 299
TABLE 225 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 300
TABLE 226 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 301
TABLE 227 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 302
TABLE 228 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 303
TABLE 229 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 304
10.5.4 SOUTH AFRICA 304
10.5.4.1 NHI scheme, increased government spending on healthcare, and priority programs to propel market 304
TABLE 230 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 305
TABLE 231 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 306
TABLE 232 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 307
TABLE 233 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 308
TABLE 234 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 309
TABLE 235 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 310
TABLE 236 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 311
TABLE 237 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 312
10.5.5 REST OF MIDDLE EAST & AFRICA 312
TABLE 238 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 313
TABLE 239 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 314
TABLE 240 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 315
TABLE 241 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 316
TABLE 242 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 317
TABLE 243 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 318
TABLE 244 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 319
TABLE 245 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 320
10.6 SOUTH AMERICA 320
10.6.1 RECESSION IMPACT 321
TABLE 246 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 321
TABLE 247 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 321
TABLE 248 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2020–2023 (KILOTON) 321
TABLE 249 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2024–2029 (KILOTON) 322
TABLE 250 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 322
TABLE 251 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 323
TABLE 252 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 324
TABLE 253 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 325
TABLE 254 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 326
TABLE 255 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 327
TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 328
TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 329
TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (USD MILLION) 329
TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (USD MILLION) 330
TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2020–2023 (KILOTON) 330
TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2024–2029 (KILOTON) 330
10.6.2 BRAZIL 331
10.6.2.1 Growing aging population, expanding economy, and increasing health awareness to drive market 331
TABLE 262 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 332
TABLE 263 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 333
TABLE 264 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 334
TABLE 265 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 335
TABLE 266 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 336
TABLE 267 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 337
TABLE 268 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 338
TABLE 269 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 339
10.6.3 ARGENTINA 339
10.6.3.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry 339
TABLE 270 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 340
TABLE 271 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 341
TABLE 272 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 342
TABLE 273 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 343
TABLE 274 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 344
TABLE 275 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 345
TABLE 276 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 346
TABLE 277 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 347
10.6.4 REST OF SOUTH AMERICA 347
TABLE 278 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (USD MILLION) 348
TABLE 279 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (USD MILLION) 349
TABLE 280 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2020–2023 (KILOTON) 350
TABLE 281 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2024–2029 (KILOTON) 351
TABLE 282 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 352
TABLE 283 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 353
TABLE 284 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2020–2023 (KILOTON) 354
TABLE 285 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2024–2029 (KILOTON) 355
11 COMPETITIVE LANDSCAPE 356
11.1 OVERVIEW 356
11.2 KEY PLAYER STRATEGIES 357
FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2024 357
11.3 MARKET SHARE ANALYSIS 358
11.3.1 RANKING OF KEY MARKET PLAYERS, 2023 358
FIGURE 40 RANKING OF TOP FIVE PLAYERS IN MEDICAL POLYMER MARKET, 2023 358
11.3.2 MARKET SHARE ANALYSIS OF KEY PLAYERS 358
TABLE 286 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION 358
FIGURE 41 MEDICAL POLYMER MARKET: SHARE OF KEY PLAYERS 359
11.3.2.1 BASF SE 359
11.3.2.2 SABIC 359
11.3.2.3 Covestro AG 360
11.3.2.4 Celanese Corporation 360
11.3.2.5 Evonik Industries 360
11.4 REVENUE ANALYSIS 361
FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2021–2024 361
11.5 COMPANY VALUATION AND FINANCIAL METRICS 362
FIGURE 43 COMPANY VALUATION OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023 362
FIGURE 44 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL POLYMER MARKET, 2023 363
11.6 BRAND/PRODUCT COMPARISON 363
FIGURE 45 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON 363
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 364
11.7.1 STARS 364
11.7.2 EMERGING LEADERS 364
11.7.3 PERVASIVE PLAYERS 364
11.7.4 PARTICIPANTS 364
FIGURE 46 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX, 2023 365
11.7.5 COMPANY FOOTPRINT 365
11.7.5.1 Company overall footprint 365
11.7.5.2 Company type footprint 366
11.7.5.3 Company application footprint 367
11.7.5.4 Company region footprint 368
11.8 COMPANY EVALUATION MATRIX: START-UPS AND SMES 369
11.8.1 PROGRESSIVE COMPANIES 369
11.8.2 RESPONSIVE COMPANIES 369
11.8.3 DYNAMIC COMPANIES 369
11.8.4 STARTING BLOCKS 370
FIGURE 47 MEDICAL POLYMER MARKET: START-UPS/SMES EVALUATION MATRIX, 2023 370
11.8.5 COMPETITIVE BENCHMARKING 371
TABLE 287 MEDICAL POLYMER MARKET: DETAILED LIST OF KEY START-UPS/SMES 371
TABLE 288 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 372
11.9 COMPETITIVE SCENARIO AND TRENDS 372
11.9.1 PRODUCT LAUNCHES 372
TABLE 289 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, NOVEMBER 2021−MARCH 2024 373
11.9.2 DEALS 374
TABLE 290 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021–MARCH 2024 374
11.9.3 EXPANSIONS 376
TABLE 291 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024 376
12 COMPANY PROFILES 379
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats) *
12.1 MAJOR PLAYERS 379
12.1.1 BASF SE 379
TABLE 292 BASF SE: COMPANY OVERVIEW 379
FIGURE 48 BASF SE: COMPANY SNAPSHOT 380
TABLE 293 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 380
TABLE 294 BASF SE: DEALS, JANUARY 2021–MARCH 2024 381
12.1.2 SABIC 383
TABLE 295 SABIC: COMPANY OVERVIEW 383
FIGURE 49 SABIC: COMPANY SNAPSHOT 384
TABLE 296 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 385
TABLE 297 SABIC: DEALS, JANUARY 2021–MARCH 2024 386
12.1.3 COVESTRO AG 388
TABLE 298 COVESTRO AG: COMPANY OVERVIEW 388
FIGURE 50 COVESTRO AG: COMPANY SNAPSHOT 389
TABLE 299 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 389
TABLE 300 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 390
TABLE 301 COVESTRO AG: EXPANSIONS, JANUARY 2021–MARCH 2024 390
12.1.4 CELANESE CORPORATION 392
TABLE 302 CELANESE CORPORATION: COMPANY OVERVIEW 392
FIGURE 51 CELANESE CORPORATION: COMPANY SNAPSHOT 393
TABLE 303 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 393
TABLE 304 CELANESE CORPORATION: DEALS, JANUARY 2021–MARCH 2024 394
TABLE 305 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2024 395
12.1.5 EVONIK INDUSTRIES 396
TABLE 306 EVONIK INDUSTRIES: COMPANY OVERVIEW 396
FIGURE 52 EVONIK INDUSTRIES: COMPANY SNAPSHOT 397
TABLE 307 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 398
TABLE 308 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 398
TABLE 309 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–MARCH 2024 399
12.1.6 ARKEMA 401
TABLE 310 ARKEMA: COMPANY OVERVIEW 401
FIGURE 53 ARKEMA: COMPANY SNAPSHOT 402
TABLE 311 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 402
TABLE 312 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 403
TABLE 313 ARKEMA: EXPANSIONS, JANUARY 2021–MARCH 2024 403
12.1.7 SOLVAY 405
TABLE 314 SOLVAY: COMPANY OVERVIEW 405
FIGURE 54 SOLVAY: COMPANY SNAPSHOT 406
TABLE 315 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 407
12.1.8 KURARAY CO., LTD. 409
TABLE 316 KURARAY CO., LTD.: COMPANY OVERVIEW 409
FIGURE 55 KURARAY CO., LTD.: COMPANY SNAPSHOT 410
TABLE 317 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 410
TABLE 318 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021–MARCH 2024 411
12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC. 412
TABLE 319 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW 412
TABLE 320 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 412
TABLE 321 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021–MARCH 2024 413
TABLE 322 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021–MARCH 2024 413
12.1.10 DUPONT 415
TABLE 323 DUPONT: COMPANY OVERVIEW 415
FIGURE 56 DUPONT: COMPANY SNAPSHOT 416
TABLE 324 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 416
TABLE 325 DUPONT: DEALS, JANUARY 2021–MARCH 2024 417
TABLE 326 DUPONT: EXPANSIONS, JANUARY 2021–MARCH 2024 417
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Key strengths, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 419
12.2.1 TRINSEO 419
TABLE 327 TRINSEO: COMPANY OVERVIEW 419
12.2.2 KRATON CORPORATION 420
TABLE 328 KRATON CORPORATION: COMPANY OVERVIEW 420
12.2.3 TOTAL PLASTICS 421
TABLE 329 TOTAL PLASTICS: COMPANY OVERVIEW 421
12.2.4 SIMONA AMERICA 422
TABLE 330 SIMONA AMERICA: COMPANY OVERVIEW 422
12.2.5 DSM 423
TABLE 331 DSM: COMPANY OVERVIEW 423
12.2.6 INVIBIO 424
TABLE 332 INVIBIO: COMPANY OVERVIEW 424
12.2.7 AVIENT CORPORATION 424
TABLE 333 AVIENT CORPORATION: COMPANY OVERVIEW 424
12.2.8 RTP COMPANY 425
TABLE 334 RTP COMPANY: COMPANY OVERVIEW 425
12.2.9 TEKNIPLEX 426
TABLE 335 TEKNIPLEX: COMPANY OVERVIEW 426
12.2.10 TEKNOR APEX 427
TABLE 336 TEKNOR APEX: COMPANY OVERVIEW 427
12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS 428
TABLE 337 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW 428
12.2.12 WACKER CHIMIE 429
TABLE 338 WACKER CHIMIE: COMPANY OVERVIEW 429
12.2.13 HARDIE POLYMERS 430
TABLE 339 HARDIE POLYMERS: COMPANY OVERVIEW 430
12.2.14 ELIX POLYMERS 431
TABLE 340 ELIX POLYMERS: COMPANY OVERVIEW 431
12.2.15 INNOVATIVE POLYMER COMPOUNDS 432
TABLE 341 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW 432
13 APPENDIX 433
13.1 DISCUSSION GUIDE 433
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 436
13.3 CUSTOMIZATION OPTIONS 438
13.4 RELATED REPORTS 438
13.5 AUTHOR DETAILS 439